JP2011078421A5 - - Google Patents

Download PDF

Info

Publication number
JP2011078421A5
JP2011078421A5 JP2010254743A JP2010254743A JP2011078421A5 JP 2011078421 A5 JP2011078421 A5 JP 2011078421A5 JP 2010254743 A JP2010254743 A JP 2010254743A JP 2010254743 A JP2010254743 A JP 2010254743A JP 2011078421 A5 JP2011078421 A5 JP 2011078421A5
Authority
JP
Japan
Prior art keywords
inclusion body
protein
heterologous protein
proteins
regulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010254743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011078421A (ja
Filing date
Publication date
Priority claimed from SI200200187A external-priority patent/SI21273A/sl
Application filed filed Critical
Publication of JP2011078421A publication Critical patent/JP2011078421A/ja
Publication of JP2011078421A5 publication Critical patent/JP2011078421A5/ja
Withdrawn legal-status Critical Current

Links

JP2010254743A 2002-07-31 2010-11-15 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法 Withdrawn JP2011078421A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200200187A SI21273A (sl) 2002-07-31 2002-07-31 Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004526684A Division JP4703186B2 (ja) 2002-07-31 2003-06-11 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法

Publications (2)

Publication Number Publication Date
JP2011078421A JP2011078421A (ja) 2011-04-21
JP2011078421A5 true JP2011078421A5 (https=) 2012-02-23

Family

ID=31713326

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004526684A Expired - Fee Related JP4703186B2 (ja) 2002-07-31 2003-06-11 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法
JP2010254743A Withdrawn JP2011078421A (ja) 2002-07-31 2010-11-15 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004526684A Expired - Fee Related JP4703186B2 (ja) 2002-07-31 2003-06-11 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法

Country Status (9)

Country Link
US (1) US20050283000A1 (https=)
EP (1) EP1527188B1 (https=)
JP (2) JP4703186B2 (https=)
AR (1) AR040719A1 (https=)
AT (1) ATE456665T1 (https=)
AU (1) AU2003250347A1 (https=)
DE (1) DE60331149D1 (https=)
SI (2) SI21273A (https=)
WO (1) WO2004015124A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21639A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtski pripravek, ki vsebuje nemicelarne sulfobetaine
EP1939212A1 (en) * 2006-12-20 2008-07-02 LEK Pharmaceuticals D.D. Organic compounds
WO2008096370A2 (en) * 2007-02-05 2008-08-14 Natco Pharma Limited An efficient and novel purification method of recombinant hg-csf
WO2008133141A1 (ja) * 2007-04-24 2008-11-06 Toyo Boseki Kabushiki Kaisha オスモチン組換えタンパク質およびその製造方法、並びにその利用
DE202008017456U1 (de) 2007-08-27 2009-08-27 Biogenerix Ag Flüssig-Formulierung von G-CSF-Konjugaten
US20090294362A1 (en) * 2008-05-30 2009-12-03 Persson Jonas Par Stationary phase for hydrophilic interaction chromatography
WO2011109556A2 (en) * 2010-03-04 2011-09-09 Pfenex Inc. Method for producing soluble recombinant interferon protein without denaturing
NZ603033A (en) 2010-04-01 2014-06-27 Pfenex Inc Methods for g-csf production in a pseudomonas host cell
JP5836621B2 (ja) 2011-03-31 2015-12-24 株式会社マキタ 動力工具
HUP1200172A2 (en) 2012-03-19 2013-10-28 Richter Gedeon Nyrt Methods for refolding g-csf from inclusion bodies
HUP1200171A1 (hu) 2012-03-19 2013-09-30 Richter Gedeon Nyrt Módszerek polipeptidek elõállítására
EP3744728A1 (en) 2013-02-12 2020-12-02 Bristol-Myers Squibb Company Tangential flow filtration based protein refolding methods
ES2870802T3 (es) 2013-02-12 2021-10-27 Bristol Myers Squibb Co Métodos de replegado de proteínas a elevado pH
WO2015063613A2 (en) * 2013-11-01 2015-05-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
CN104152515B (zh) * 2014-08-14 2019-12-31 江苏奥赛康药业有限公司 一种制备重组人粒细胞集落刺激因子的培养基及发酵方法
JP2020080727A (ja) * 2018-11-26 2020-06-04 Ｓｐｉｂｅｒ株式会社 目的タンパク質の製造方法
AU2021286574A1 (en) * 2020-06-09 2023-01-19 Icosavax, Inc. Method of making virus-like particle

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
IE912365A1 (en) * 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
DE4037196A1 (de) * 1990-11-22 1992-05-27 Boehringer Mannheim Gmbh Verfahren zur reaktivierung von denaturiertem protein
AU6028396A (en) * 1995-06-07 1996-12-30 Amgen, Inc. Ob protein compositions and method
US5912327A (en) * 1996-09-30 1999-06-15 Human Genome Sciences, Inc. Method of purifying chemokines from inclusion bodies
CN1154723C (zh) * 1996-12-27 2004-06-23 日本烟草产业株式会社 花器特异性基因及其启动子序列
US20020052026A1 (en) * 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6677139B1 (en) * 1999-12-23 2004-01-13 Genecor International, Inc. Methods for production of proteins in host cells
US6936437B2 (en) * 2001-02-23 2005-08-30 Lucia Irene Gonzalez-Villasenor Methods and compositions for production of recombinant peptides
SI21102A (sl) * 2001-12-19 2003-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika

Similar Documents

Publication Publication Date Title
JP2011078421A5 (https=)
IL281648A (en) Solid forms of }[5-(3-chlorophenyl)-3-hydroxypyridi-2-carbonyl]amino{ acetic acid, their compositions and uses
WO2012163869A3 (en) Composition comprising an alkoxysilane and a modified starch, and cosmetic use thereof
ZA201201791B (en) Method for the preparation of 2,5-furandicarboxylic acid and esters thereof
JP2012097086A5 (https=)
JP2009256391A5 (https=)
JP2011037901A5 (https=)
PL2352386T3 (pl) Sposób wytwarzania związku kwasu n-masłowego w postaci mikrokapsułkowanej do spożycia przez zwierzęta lub ludzi
ZA201202387B (en) Particulate composition containing anhtdrous crystalline of 2-o-a-d-glucosyl-l-ascorbic acid,process for producing the same, and uses thereof
UA105487C2 (uk) Заміщені дигідропіразолони як інгібітори hif-проліл-4-гідроксилази
WO2012175743A3 (en) Methods for the production of a cosmetic composition from hatching fluid of salmonidae eggs and uses thereof for improving the cosmetic appearance of skin
EA201491112A1 (ru) Перколированный муллит и способ его получения
WO2012175742A3 (en) Methods for the production of a cosmetic composition comprising leukolectin and uses thereof
WO2012151242A3 (en) Lignin-based nanostructures
WO2012010978A3 (en) A method of treating alzheimer's disease
CA2899024C (en) Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
PL395002A1 (pl) Hybrydowy material zawierajacy nanoczastki srebra, sposób wytwarzania materialu hybrydowego oraz jego zastosowanie
EP2609815A4 (en) PROCESS FOR PRODUCTION OF FISH PASTE PRODUCT, AND ENZYMA PREPARATION FOR MODIFICATION OF FISH PASTE PRODUCT
JP2008280345A5 (https=)
WO2011139752A3 (en) Preparation of polypeptides and salts thereof
WO2012150607A3 (en) Oral liquid composition comprising divalproex sodium and process for preparing thereof
JP2010285408A5 (https=)
EP2590764B8 (en) Method for the production of an element subject to wear, element subject to wear and temporary aggregation structure to produce said element subject to wear
JP2012085613A5 (https=)
PL392283A1 (pl) Nowe pochodne aldehydu lub kwasu 4-cykloheksylo-5-nitro-2-oksopentanowego, sposób ich wytwarzania oraz ich zastosowanie